Issued Patents All Time
Showing 26–50 of 53 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 6171806 | Isolated peptide defined by SEQ ID NO: 17 and uses thereof | Jean Herman, Pierre van der Bruggen, Thierry Boon-Falleur | 2001-01-09 |
| 6153728 | Isolated tumor rejection antigen precursor MAGE-10 and compositions containing it | Donata Rimoldi, Victor Jongeneel, Jean-Charles Cerrottini, Stefan Carrel, Daryl Reed | 2000-11-28 |
| 6130052 | Leukemia associated genes | Nicolas Van Baren, Charles DeSmet, Sophie Lucas, Thierry Boon-Falleur | 2000-10-10 |
| 6110694 | Methods for determining complexes of tumor rejection antigens and HLA-Cw*160/molecules | Pascale Boel, Claude Wildmann, Thierry Boon-Falleur, Pierre van der Bruggen, Jean-Christophe Renauld | 2000-08-29 |
| 6093540 | Method for diagnosing a disorder characterized by expression of a BAGE tumor rejection antigen precursor | Pierre van der Bruggen, Thierry Boon-Falleur, Jean-Christophe Renauld | 2000-07-25 |
| 6060257 | Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof | Jean Herman, Thierry Boon-Falleur, Pierre van der Bruggen, Immanuel F. Luescher | 2000-05-09 |
| 6022692 | Method for screening for possible presence of cancer | Hideyuki Ikeda, Thierry Boon-Falleur | 2000-02-08 |
| 6013765 | Isolated tumor rejection antigens derived from DAGE tumor rejection antigen precusor | Hideyuki Ikeda, Thierry Boon-Falleur | 2000-01-11 |
| 5997870 | Isolated peptides which bind to HLA-B44 Molecules | Thierry Boon-Falleur | 1999-12-07 |
| 5977300 | Isolated nonapeptide which bind to HLA-B44 molecules and the uses thereof | Jean Herman, Pierre van der Bruggen, Thierry Boon-Falleur | 1999-11-02 |
| 5908778 | Mage-10 encoding cDNA, the tumor rejection antigen precursor mage-10, antibodies specific to the molecule, and uses thereof | Donata Rimoldi, Victor Jongeneel, Jean-Charles Cerrottini, Stefan Carrel, Daryl Reed | 1999-06-01 |
| 5879892 | Leukemia associated genes | Nicolas Van Baren, Charles DeSmet, Sophie Lucas, Thierry Boon-Falleur | 1999-03-09 |
| 5877017 | Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecule HLA-Cw*1601 and uses thereof | Pascale Boel, Claude Wildmann, Thierry Boon-Falleur, Pierre van der Bruggen, Jean-Christophe Renauld | 1999-03-02 |
| 5856091 | Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 | Vincent Brichard, Aline Van Pel, Catia Traversari, Thomas Wolfel, Thierry Boon-Falleur +1 more | 1999-01-05 |
| 5851523 | Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof | Alan Townsend, Judy Bastin, Thierry Boon-Falleur, Pierre van der Bruggen, Thomas F. Gajewski | 1998-12-22 |
| 5846826 | Isolated cytolytic T cell line specific to complexes of HLA-B44 molecules and specific nonapeptides | Thierry Boon-Falleur | 1998-12-08 |
| 5843688 | Isolated tyrosinase derived peptides and uses thereof | Thomas Wolfel, Aline Van Pel, Vincent Brichard, Thierry Boon-Falleur, Etienne DePlaen +2 more | 1998-12-01 |
| 5830753 | Isolated nucleic acid molecules coding for tumor rejection antigen precursor dage and uses thereof. | Hideyuki Ikeda, Thierry Boon-Falleur | 1998-11-03 |
| 5747271 | Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of HLA-A2/tyrosinase derived peptides, and methods for treating said individuals | Thierry Boon-Falleur, Vincent Brichard, Aline Van Pel, Etienne De Plaen, Jean-Christope Renauld +1 more | 1998-05-05 |
| 5744353 | Cytolytic T cell lines which bind to complexes of tumor rejection antigens and HLA-B44 molecules | Jean Herman, Thierry Boon-Falleur, Pierre van der Bruggen, Immanuel F. Luescher | 1998-04-28 |
| 5591430 | Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof | Alan Townsend, Judy Bastin, Thierry Boon-Falleur, Pierre van der Bruggen, Thomas F. Gajewski | 1997-01-07 |
| 5589334 | Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor which is processed to an antigen presented by HLA-B44, and uses thereof | Thierry Boon-Falleur | 1996-12-31 |
| 5585461 | Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof | Alan Townsend, Judy Bastin, Thierry Boon-Falleur, Pierre van der Bruggen | 1996-12-17 |
| 5571711 | Isolated nucleic acid molecules coding for BAGE tumor rejection antigen precursors | Pierre van der Bruggen, Thierry Boon-Falleur, Jean-Christophe Renauld | 1996-11-05 |
| 5530096 | Isolated, tyrosinase derived peptides and uses thereof | Thomas Wolfel, Aline Van Pel, Vincent Brichard, Thierry Boon-Falleur, Etienne DePlaen +2 more | 1996-06-25 |